Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Diabetes, Obesity & Metabolism
|
April 29, 2024
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme
Richard M Bergenstal, Athena Philis-Tsimikas, Carol Wysham, et al.
Lancet (London, England)
|
June 25, 2025
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
Thomas Blevins, Dominik Dahl, Federico C Pérez Manghi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 18, 2025
Safety and Efficacy of Inhaled Technosphere<sup>®</sup> Insulin in the Postprandial Period With Modified Initial Dose Conversion
Christopher Jacobson, Kevin B Kaiserman, Johanna Ulloa, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 12, 2021
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
George Grunberger, Jennifer Sherr, Myriam Allende, et al.
The New England Journal of Medicine
|
June 23, 2023
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Sean Wharton, Thomas Blevins, Lisa Connery, et al.
Diabetes Care
|
September 15, 2025
Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level
Irl B Hirsch, Yogish C Kudva, David T Ahn, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 24, 2016
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY
Vivian A Fonseca, George Grunberger, Henry Anhalt, et al.
Diabetes Technology & Therapeutics
|
March 18, 2025
A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes
Roy W Beck, Ryan J Bailey, Halis K Akturk, et al.
Molecular Metabolism
|
June 11, 2025
Methylglyoxal-induced RNA modifications decrease RNA stability and translation and are associated with type 2 diabetes
Edwin De Jesus Lopez Gonzalez, Seigmund Wai Tsuen Lai, Kelani Sun, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
January 17, 2024
Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes
Carol J Levy, Dan Raghinaru, Yogish C Kudva, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Diabetes, Obesity & Metabolism
|
April 29, 2024
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme
Richard M Bergenstal, Athena Philis-Tsimikas, Carol Wysham, et al.
Lancet (London, England)
|
June 25, 2025
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
Thomas Blevins, Dominik Dahl, Federico C Pérez Manghi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 18, 2025
Safety and Efficacy of Inhaled Technosphere<sup>®</sup> Insulin in the Postprandial Period With Modified Initial Dose Conversion
Christopher Jacobson, Kevin B Kaiserman, Johanna Ulloa, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 12, 2021
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
George Grunberger, Jennifer Sherr, Myriam Allende, et al.
The New England Journal of Medicine
|
June 23, 2023
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Sean Wharton, Thomas Blevins, Lisa Connery, et al.
Diabetes Care
|
September 15, 2025
Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level
Irl B Hirsch, Yogish C Kudva, David T Ahn, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 24, 2016
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY
Vivian A Fonseca, George Grunberger, Henry Anhalt, et al.
Diabetes Technology & Therapeutics
|
March 18, 2025
A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes
Roy W Beck, Ryan J Bailey, Halis K Akturk, et al.
Molecular Metabolism
|
June 11, 2025
Methylglyoxal-induced RNA modifications decrease RNA stability and translation and are associated with type 2 diabetes
Edwin De Jesus Lopez Gonzalez, Seigmund Wai Tsuen Lai, Kelani Sun, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
January 17, 2024
Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes
Carol J Levy, Dan Raghinaru, Yogish C Kudva, et al.
Page
of 4